Dynatrace (DT) Q1 2025 earnings summary

Executive summary

• Annual recurring revenue (ARR) reached $1.54 billion as of June 30, 2024, up 20% year-over-year in constant currency, with net new ARR of $46 million, and subscription revenue grew 21% to $382 million, exceeding guidance.

• Free cash flow was $227 million in Q1, representing over 50% of full-year guidance, and 30% of revenue on a trailing twelve-month basis.

• The company exceeded guidance across all key metrics, launched new platform extensions, and expanded product capabilities, including Kubernetes Security Posture Management and FedRAMP Moderate reauthorization.

• Management remains focused on innovation, expanding the customer base, and navigating macroeconomic challenges.

• Strengthened partnerships with AWS and Microsoft, and continued share repurchases under the $500 million program.

Financial highlights

• Total revenue was $399 million, up 20% year-over-year, or 21% in constant currency, with subscription revenue at $382 million and service revenue at $17.6 million.

• Non-GAAP gross margin was 85%, and GAAP gross margin was 81%; non-GAAP operating income was $114 million (29% margin), and non-GAAP net income was $99 million, or $0.33 per diluted share.

• Free cash flow for Q1-25 TTM was $450 million, representing 30% of revenue.

• Share-based compensation expense totaled $58 million for the quarter.

• Net cash provided by operating activities was $231 million, up from $133.9 million a year ago.

Outlook and guidance

• Full-year FY2025 guidance maintained: ARR $1.72–$1.735 billion (14–15% growth as reported, 15–16% constant currency), revenue $1.644–$1.658 billion, non-GAAP operating margin 28%, and free cash flow margin 23.5–24%.

• Q2 FY2025 revenue guidance: $404–$407 million, with subscription revenue between $388 million and $390 million, and non-GAAP operating income of $113–$116 million.

• Foreign exchange expected to be a $12 million headwind on ARR and $10 million on revenue for FY2025.

• Management remains optimistic but is taking a prudent approach due to macroeconomic uncertainty, deal timing variability, and ongoing go-to-market changes.

• Continued investment in R&D and innovation, focusing on large enterprise accounts and international expansion.